| Autor: |
Kiessling M; Department of Cardiology, Medical University of Graz, 8036 Graz, Austria., Djalinac N; Department of Biology, University of Padua, 35122 Padova, Italy., Voglhuber J; Department of Cardiology, Medical University of Graz, 8036 Graz, Austria.; BioTechMed Graz, 8010 Graz, Austria., Ljubojevic-Holzer S; Department of Cardiology, Medical University of Graz, 8036 Graz, Austria.; BioTechMed Graz, 8010 Graz, Austria.; Gottfried Schatz Research Center, Division of Molecular Biology and Biochemistry, Medical University of Graz, 8010 Graz, Austria. |
| Abstrakt: |
The nucleus of a cardiomyocyte has been increasingly recognized as a morphologically distinct and partially independent calcium (Ca 2+ ) signaling microdomain, with its own Ca 2+ -regulatory mechanisms and important effects on cardiac gene expression. In this review, we (1) provide a comprehensive overview of the current state of research on the dynamics and regulation of nuclear Ca 2+ signaling in cardiomyocytes, (2) address the role of nuclear Ca 2+ in the development and progression of cardiac pathologies, such as heart failure and atrial fibrillation, and (3) discuss novel aspects of experimental methods to investigate nuclear Ca 2+ handling and its downstream effects in the heart. Finally, we highlight current challenges and limitations and recommend future directions for addressing key open questions. |
